Table 4. Clinical outcomes between the beta-blocker and non-beta-blocker groups in patients with cardiovascular disease.
Outcome | OR (95% CI) |
Survival at 30 days | |
After multiple imputation and overlap weighting | 1.04 (0.61-1.75) |
Favorable neurological outcome at 30 days | |
After multiple imputation and overlap weighting | 1.09 (0.61-1.93) |